体外诊断(IVD)趋势与市场最新资讯:2024年12月

In Vitro Diagnostic (IVD) Trends and Market Update: December 2024

出版日期: 2024年12月09日 | 出版商:

Kalorama Information | 英文 50 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

在技术进步和不断扩大的机会的推动下，体外诊断 (IVD) 市场呈现强劲成长。诊断测试正在从简单地诊断疾病发展到为精准医学治疗提供重要见解。儘管 COVID-19 检测有所下降，但它继续对 2024 年的整体收入做出贡献。受新产品开发、全球医疗保健支出变化、监管变化和疾病趋势的影响，市场仍充满活力和弹性。

体外诊断 (IVD) 市场的多个领域正在经历显着成长并吸引了行业关注。其中包括即时 (POC) 测试、癌症诊断、伴随诊断、免疫化学和质谱分析。此外，核酸检测、基因检测和 HPV 分子诊断也有望显着成长，是未来关注的重要领域。

诊断测试现已成为医疗保健的基石，有助于诊断和治疗决策。儘管 COVID-19 检测数量有所下降，但核心诊断领域却显示持续成长。市场演变是由创新产品、全球医疗保健成本趋势、监管变化和新出现的疾病趋势等因素所驱动的。

主要成长领域包括次世代定序 (NGS)、个人化医疗和质谱。免疫化学、POC 检测和分子诊断也有望在 IVD 的未来中发挥重要作用。市场的特点是不断创新和适应。

本报告提供体外诊断(IVD)趋势与市场最新资讯的相关调查，2024年的市场趋势与成长促进因素，今后预测等最新洞察。

The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience.

Several segments within the IVD market are experiencing significant growth and attracting industry attention. These include Point-of-Care (POC) testing, cancer diagnostics, companion diagnostics, immunochemistry, and mass spectrometry. Additionally, nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for substantial growth, marking them as key areas of interest for the future.

Diagnostic testing is now a cornerstone of healthcare, aiding in both diagnosis and treatment decisions. Despite the decline in COVID-19 testing, core diagnostic segments have shown consistent growth. The market's evolution is driven by factors such as innovative products, global health expenditure changes, regulatory shifts, and emerging disease trends.

Key growth areas include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, POC testing, and molecular diagnostics are also expected to play crucial roles in the future of IVD. The market is characterized by continuous innovation and adaptation.

The report, "In Vitro Diagnostic (IVD) Trends and Market Update: December 2024" by Kalorama Information provides the latest insights into these trends and other factors shaping the market.

It covers:

Drivers of growth in the IVD market in 2024
Major trends impacting the market in 2024
Product trends and new developments shaping the IVD market in 2024

Highlighted trends from Q3 2023 to Q3 2024 include:

The increasing role of AI technologies in IVD development and testing
Exponential growth in the POC diabetes market
Double-digit growth in HPV molecular testing
Significant growth in blood banking molecular NAT screening due to advancements in nucleic acid method

Chapter 1: Worldwide IVD Market - December 2024 Update

IVD Market Demand and Growth
- Figure 1-1: Q1 2024 - Q3 2024 Segment Performance Commentary
- Table 1-1: Global In Vitro Diagnostic Sales, by Product Market, 2024 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
- Figure 1-2: IVD Segment Performance, Q1 2024 - Q4 2024 estimated ($ million) (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other)
- Figure 1-3: IVD Segment Performance, Total Market Value, 2024 estimated ($ million) (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other)
COVID-19 Diagnostic Markets
- Table 1-2: COVID-19 Product Sales, by Segment, 2024 ($ million) (Immunoassay [Antigen and Serology], Molecular, Rapid [POC Professional and POC At-Home])
Effect of COVID-19 on Market Segments
- Table 1-3: IVD Market excluding and with COVID-19, 2024 ($ million)
- Figure 1-4: IVD Market Distribution, by Segment, 2024 (%) (IVD Market excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments)
- Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, Q1 2024 - Q4 2024 estimated ($ million)
- Table 1-4: Global In Vitro Diagnostic Market - YoY Growth, 2023-2024 (%) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
- Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth, 2023-2024 (%) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)

Chapter 2: Product Trends and New Developments

Selected New - Q3 2024 - Core IVD Product Launches, Developments and Trends
Flow Cytometry
Immunoassay
Molecular
Personalized Medicine
POC
Sequencing
Selected COVID-19 Developments - Q3 2024
- Figure 2-1: COVID-19 Test Market, by Type, Q1 2024 - Q4 2024 estimated ($ million) (Antigen, Molecular, Rapid, Serology)
Antigen/Antibody
Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates
- Figure 3-1: IVD Segment Growth, by Leading Competitors, Change in Sales, 2023-2024 (%) (Abbott Diagnostics, Becton Dickinson, bioMerieux, Danaher, Dexcom, Exact Sciences, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific)
- Figure 3-2: Top 10 IVD Companies: Changes in Market Distribution for IVD Sales, 2021-2024 estimated - Roche and Abbott Battle for #1 Spot (%) (Abbott Diagnostics, Becton Dickinson, bioMerieux, Danaher, Dexcom, Exact Sciences, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific)
- Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2022-2024 ($ million)
Q3 M&A Activity
- Table 3-1: Q3 2024 Merger and Acquisition Activity
Abbott Laboratories
- Table 3-2: Abbott Corporate Summary
Becton Dickinson and Co
- Table 3-3: Becton Dickinson Corporate Summary
bioMerieux SA
- Table 3-4: bioMerieux Corporate Summary
Danaher Corporation
- Table 3-5: Danaher Corporation Summary
Dexcom, Inc.
- Table 3-6: Dexcom Corporate Summary
Exact Sciences
- Table 3-7: Exact Sciences Corporate Summary
Roche Diagnostic
- Table 3-8: Roche Diagnostic Corporate Summary
Siemens Healthineers
- Table 3-9: Siemens Healthineers Corporate Summary
Sysmex Corporation
- Table 3-10: Sysmex Corporate Summary
Thermo Fisher Scientific
- Table 3-11: Thermo Fisher Scientific Corporate Summary